Baroda BNP Paribas Health and Wellness Fund Regular Growth
₹9.8556
₹0.16 (-1.61%)
NAV as of 29 May 2026
Today's NAV — all variants
Regular · Growth
₹₹9.8556
₹0.16 (-1.61%)
29 May 2026
AMFI: 153602
Direct · Growth
₹₹10.0199
₹0.16 (-1.60%)
29 May 2026
AMFI: 153604
Regular · IDCW
₹₹9.8556
₹0.16 (-1.61%)
29 May 2026
AMFI: 153607
Direct · IDCW
₹₹10.0199
₹0.16 (-1.60%)
29 May 2026
AMFI: 153605
Returns (Lumpsum)
CAGR for periods ≥ 1 yearSIP Returns (XIRR)
₹1,000/month SIP, annualisedSIP since inception — what ₹500/month became
Real NAV backtest from day one
₹5,500
Invested
₹5,673
Value today
6.5%
XIRR (p.a.)
₹500/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹1,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹1,000
Invested
₹986
Value today
-1.6%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹6,34,230
Value today
+7.3%
vs lumpsum
STP beat direct lumpsum by 7.3% — reduced timing risk paid off
Model your own STP with real NAVBeat the benchmark — ₹500/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹5,673
Benchmark
₹5,435
+₹238 extra wealth vs the benchmark index
Backtest this SIP yourselfFund Details
Portfolio Holdings
Top 50 holdings · as of Mar 2026
| Security | % NAV |
|---|---|
Sun Pharmaceutical Industries Limited INE044A01036 | 9.38% |
Lupin Limited INE326A01037 | 6.09% |
IPCA Laboratories Limited INE571A01038 | 5.34% |
Abbott India Limited INE358A01014 | 5.28% |
Torrent Pharmaceuticals Limited INE685A01028 | 5.13% |
Laurus Labs Limited INE947Q01028 | 4.78% |
Fortis Healthcare Limited INE061F01013 | 4.35% |
Apollo Hospitals Enterprise Limited INE437A01024 | 4.32% |
JB Chemicals & Pharmaceuticals Limited INE572A01036 | 4.24% |
AstraZeneca Pharma India Limited INE203A01020 | 4.03% |
Emcure Pharmaceuticals Limited INE168P01015 | 3.44% |
SBI Life Insurance Company Limited INE123W01016 | 3.43% |
Aster DM Healthcare Limited INE914M01019 | 2.97% |
ICICI Prudential Life Insurance Company Limited INE726G01019 | 2.81% |
Glenmark Pharmaceuticals Limited INE935A01035 | 2.72% |
Aurobindo Pharma Limited INE406A01037 | 2.62% |
Dr. Lal Path Labs Limited INE600L01024 | 2.58% |
Gland Pharma Limited INE068V01023 | 2.09% |
Divi's Laboratories Limited INE361B01024 | 2.07% |
Ajanta Pharma Limited INE031B01049 | 1.86% |
Acutaas Chemicals Limited INE00FF01025 | 1.76% |
MedPlus Health Services Limited INE804L01022 | 1.64% |
Inventurus Knowledge Solutions Limited INE115Q01022 | 1.56% |
Nephrocare Health Services Ltd INE428V01029 | 1.50% |
| Security | % NAV |
|---|---|
Sun Pharmaceutical Industries Limited INE044A01036 | 10.23% |
Lupin Limited INE326A01037 | 6.29% |
Abbott India Limited INE358A01014 | 5.53% |
Torrent Pharmaceuticals Limited INE685A01028 | 5.32% |
IPCA Laboratories Limited INE571A01038 | 5.28% |
Laurus Labs Limited INE947Q01028 | 4.43% |
JB Chemicals & Pharmaceuticals Limited INE572A01036 | 4.41% |
AstraZeneca Pharma India Limited INE203A01020 | 3.92% |
SBI Life Insurance Company Limited INE123W01016 | 3.45% |
Emcure Pharmaceuticals Limited INE168P01015 | 3.36% |
Aster DM Healthcare Limited INE914M01019 | 3.25% |
Apollo Hospitals Enterprise Limited INE437A01024 | 3.24% |
Fortis Healthcare Limited INE061F01013 | 3.09% |
Gland Pharma Limited INE068V01023 | 2.96% |
ICICI Prudential Life Insurance Company Limited INE726G01019 | 2.87% |
Dr. Lal Path Labs Limited INE600L01024 | 2.55% |
Aurobindo Pharma Limited INE406A01037 | 2.53% |
Max Healthcare Institute Limited INE027H01010 | 2.33% |
Rainbow Childrens Medicare Limited INE961O01016 | 2.26% |
Divi's Laboratories Limited INE361B01024 | 1.95% |
Ajanta Pharma Limited INE031B01049 | 1.91% |
Acutaas Chemicals Limited INE00FF01025 | 1.74% |
MedPlus Health Services Limited INE804L01022 | 1.63% |
Dr. Reddy's Laboratories Limited INE089A01031 | 1.58% |
Nephrocare Health Services Ltd INE428V01029 | 1.48% |
Poly Medicure Limited INE205C01021 | 1.39% |
Performance Comparison
Interested in This Fund?
Our experts will help you decide if this fund fits your goals.
Investment Objective
Baroda BNP Paribas Health and Wellness Fund Regular Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Baroda BNP Paribas Health and Wellness Fund Regular Growth is a Sectoral / Thematic mutual fund offered by Baroda BNP Paribas Mutual Fund. The fund has been operational for over 0 years. It manages assets worth ₹555 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 2.33%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations